Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the most common cause of legal blindness in developed countries. Neovascular (ie, wet) AMD is currently managed with intravitreal therapy. Traditional treatments (ie, bevacizumab, ranibizumab, aflibercept) provide high-efficacy therapy but can also require f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Stephanie M, Arepalli, Sruthi, Ehlers, Justis P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488047/
https://www.ncbi.nlm.nih.gov/pubmed/34616189
http://dx.doi.org/10.2147/JEP.S259298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488047/
https://www.ncbi.nlm.nih.gov/pubmed/34616189
http://dx.doi.org/10.2147/JEP.S259298

Ejemplares similares